Eli Lilly’s Obesity Drug Has Big Potential. One Way to Play the Stock.

The caveat to all that, of course, is that widespread famine or a nuclear disaster does not emerge from the current conflicts. Anyone who agrees with the rich-thin thesis can try monetizing the idea by selling cash-secured puts on Eli Lilly (ticker: LLY). With Eli Lilly’s stock at $592.33, investors could sell the November $560 put for about $10.50.